Gilbert + Tobin

Gold exploration company Zuleika Gold has to produce a draft technical report to Vango Mining as it seeks "significant damages' over a repudiated joint venture agreement, with a judge finding an affidavit from its solicitor put the report squarely in issue. 

Mayne Pharma and US drug maker Cosette have agreed to postpone the start of trial in a case over the termination of a $672 million merger to allow for late amendments.

Gilbert +Tobin’s executive partner and corporate advisory head Tim Gordon will join Corrs Chambers Westgarth’s corporate practice based after almost 20 years at G+T.

The High Court has unanimously found the Federal Court has no power to allow solicitors to take a cut of a settlement or judgment in a shareholder class action against Blue Sky, saying it would be contrary to rules against contingency fees in NSW. 

Gilbert + Tobin has strengthened its real assets team with the appointment of a partner recruited from global asset manager Blackstone.

Mayne Pharma has denied US drug maker Cosette's claims it breached its continuous disclosure obligations in relation to US FDA concerns about marketing for its Nextstellis contraceptive, as the drug makers spar over their $672 million merger.

A court has heard US drug maker Cosette may amend its case to accuse Adelaide's Mayne Pharma of continuous disclosure breaches in their battle over the termination of their $672 million merger.

A patent holding company is challenging the dismissal of its infringement case over Apple's Touch ID and Face ID technology.

Westpac can shield reports prepared by Allens from a class action over money laundering compliance, with a judge finding they were produced predominantly in defence of AUSTRAC action that preceded the case.

Five passengers who were forced off a Qatar Airways flight and strip searched at Doha International Airport have successfully appealed the summary dismissal of their case against the airline, with the Full Court finding key issues were not suited for summary determination.